PRL, prolactin, 5617

N. diseases: 506; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 GeneticVariation disease BEFREE Prevalence of macroprolactinemia was 21.57% (22/102) in hyperprolactinemia (prolactin >100 ng/ml). 30269265 2019
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 Biomarker disease BEFREE Our findings support a possible role of prolactin in emerging psychosis and it could be speculated that stress, which can induce hyperprolactinemia, has a stronger effect on women than on men in emerging psychosis. 28214176 2017
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 Biomarker disease BEFREE The occurrence of big-big prolactin (PRL) as the major form of circulating immunoactive PRL has been described in ovulatory hyperprolactinemia. 3595901 1987
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 Biomarker disease BEFREE From a total of 174 people with serum prolactin measurements at study recruitment, 43% (n=74) had HPL, whilst 27% (n=21/78) and 27% (n=26/95) had HPL at 3 and 12months respectively. 28755878 2017
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 AlteredExpression disease BEFREE The total cholesterol (baseline, 236.1 ± 47.6 mg/dl; endpoint [week 12], 209.9 ± 28.0 mg/dl; p = 0.005) and prolactin levels (baseline, 80.0 ± 85.2 ng/ml; endpoint [week 12], 63.2 ± 88.9 ng/ml; p = 0.003) were also significantly improved in patients with hypercholesterolemia or hyperprolactinemia. 31352709 2019
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 Biomarker disease BEFREE Key aspects include asymptomatic hyperprolactinemia monitoring and fertility considerations with PRL normalisation. 28889207 2017
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 AlteredExpression disease BEFREE The study population consisted of 3 age-, weight-, and lipid-matched groups of young women: 19 women with untreated hyperprolactinemia (group A), 20 normoprolactinemic women receiving bromocriptine treatment (because of previous hyperprolactinemia) (group B), and 20 untreated women with prolactin levels within the reference range (group C). 30129670 2019
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 AlteredExpression disease BEFREE Some studies have reported that hyperprolactinemia is more common in RA and serum PRL levels are correlated with several disease parameters, although others could not confirm these findings. 28690611 2017
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 Biomarker disease CTD_human Development of anti-PRL (prolactin) autoantibodies by homologous PRL in rats: a model for macroprolactinemia. 17303669 2007
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 AlteredExpression disease BEFREE High blood levels of PRL are associated with a poor prognosis in metastatic breast cancer whereas hyperprolactinemia after breast surgery may predict a better prognosis in women with operable breast cancer. 19181018 2009
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 Biomarker disease BEFREE The present study thus suggests that female patients with the A1 allele show greater prolactin response to bromperidol, who may have a high risk for adverse effects associated with neuroleptic-induced hyperprolactinemia. 11353448 2001
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 AlteredExpression disease BEFREE The study population included 11 men with isolated macroprolactinemia, 14 subjects with monomeric hyperprolactinemia and 14 men with prolactin levels within the reference range. 31185509 2019
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 Biomarker disease LHGDN Pituitary production of prolactin and prolactin-suppressing drugs. 11721691 2001
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 AlteredExpression disease BEFREE The study enrolled 30 young women with mild hyperprolactinemia (serum prolactin levels in the range between 25 and 50ng/mL), 15 of whom were later treated with bromocriptine (5-10mg daily), as well as 14 age- and weight-matched healthy women. 29475005 2018
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 Biomarker disease BEFREE A total of 95% of the 20 patients with hyperprolactinemia had progressive disease (PD), according to CT results, whereas only 2 patients (33%) out of 6 with stable PRL levels had PD (p = 0.004). 28407622 2017
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 Biomarker disease BEFREE Univariate survival analysis showed that patients with pretherapeutic hyperprolactinemia had a significantly shorter overall survival than patients with pretherapeutic PRL <15.0 ng/mL serum (p =.0009). 10748449 2000
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 Biomarker disease BEFREE This review aims to summarize current knowledge about PRL and its receptor, role in reproductive axis and presents information of hyperprolactinemia in reproductive medicine. 17307904 2007
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 AlteredExpression disease BEFREE Prolactin takes calcium from the skeletal system following increased Prlr gene expression in the vertebrae to maintain calcium homeostasis, which increases the harmful effect on bone metabolism compared to that of physiological hyperprolactinaemia. 30143940 2018
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 AlteredExpression disease BEFREE Abnormalities in thyroid function and hyperprolactinemia are well-known causes of infertility, but whether thyrotropin (TSH) and prolactin levels within the normal range are associated with UI is unknown. 29272395 2018
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 AlteredExpression disease BEFREE Big big PRL or macroprolactin is a PRL variant with reduced bioactivity towards its homologous receptor, and this altered bioactivity may contribute to the lower disease activity and absence of symptoms related to HPRL in SLE patients. 17516622 2007
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 AlteredExpression disease BEFREE Sex and age were significantly associated with PRL levels in patients treated with LAI antipsychotics, with younger women presenting higher rates of HPRL than men. 30848967 2019
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 AlteredExpression disease BEFREE Hyperprolactinemia was found to be present in Case 2, whereas Case 1 (a 49-year-old woman) had "normal" serum prolactin levels for premenopausal and prolactin levels slightly above the maximum levels for postmenopausal women. 31417404 2019
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 Biomarker disease BEFREE Although there were significant differences in the prevalence of hyperprolactinemia and metabolic syndrome according to the antipsychotic received, multivariant regression analysis did not show a correlation between sexual dysfunction and prolactin, sexual hormones, type of antipsychotic received, psychotic psychopathology or metabolic syndrome. 30552811 2018
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 AlteredExpression disease BEFREE Future prospects for hyperprolactinemia may require diagnostic criteria using free prolactin levels and so MPRL fraction measurement is important for the diagnosis and treatment of patients with obstetric and gynecological symptoms. 29162783 2018
CUI: C0020514
Disease: Hyperprolactinemia
Hyperprolactinemia
0.600 Biomarker disease BEFREE It was also demonstrated that prolactin played an important role in body weight regulation and hyperprolactinemia can promote appetite and accelerate fat deposition. 30124145 2018